Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN5A | Q14524 | 3/20 | 0.43 |
| ▸ | SCN9A | Q15858 | 3/20 | 0.43 |
| ▸ | FDPS | P14324 | 10/20 | 0.42 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21403269 | 0.98 | SCN5A (0.45) | SCN5ASCN9AFDPSGGPS1 | |
| SCHEMBL22023411 | 0.98 | SCN5A (0.45) | SCN5ASCN9AFDPSGGPS1 | |
| SCHEMBL1115356 | 0.98 | SCN5A (0.45) | SCN5ASCN9AFDPSGGPS1 | |
| SCHEMBL6940897 | 0.98 | SCN5A (0.45) | SCN5ASCN9AFDPSGGPS1 | |
| SCHEMBL31351856 | 0.98 | SCN5A (0.45) | SCN5ASCN9AFDPSGGPS1 | |
| SCHEMBL10787465 | 0.91 | SCN5A (0.45) | SCN5ASCN9AFDPSGGPS1GAA | |
| SCHEMBL9400734 | 0.89 | SCN5A (0.47) | SCN5ASCN9AFDPSGGPS1 | |
| SCHEMBL28343048 | 0.89 | SCN5A (0.47) | SCN5ASCN9AFDPSGGPS1 | |
| SCHEMBL376656 | 0.89 | SCN5A (0.47) | SCN5ASCN9AFDPSGGPS1 | |
| SCHEMBL2721692 | 0.89 | SCN5A (0.44) | SCN5ASCN9AFDPSGGPS1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3612226-A1 | COMBINATION THERAPY FOR USE IN TREATING RETROVIRAL INFECTIONS | Cipla Limited (IN) | 2020-02-26 | — | — | EP | disclosed |
| WO-2018193470-A1 | COMBINATION THERAPY FOR USE IN TREATING RETROVIRAL INFECTIONS | CIPLA LIMITED (IN) | 2018-10-25 | — | — | WO | disclosed |
| CN-105263472-A | Topical pharmaceutical composition comprising tenofovir and an antibacterial agent and optionally ciclopirox | CIPLA LTD | 2016-01-20 | — | — | CN | disclosed |
| EP-2911674-A1 | PHARMACEUTICAL ANTIRETROVIRAL COMPOSITION | Cipla Limited (IN) | 2015-09-02 | — | — | EP | disclosed |
| CN-104884063-A | Antiretroviral pharmaceutical compositions | CIPLA LTD | 2015-09-02 | — | — | CN | disclosed |
| WO-2014064409-A1 | PHARMACEUTICAL ANTIRETROVIRAL COMPOSITION | CIPLA LIMITED (IN) | 2014-05-01 | — | — | WO | disclosed |
| CN-101679414-A | Non-nucleoside reverse transcriptase inhibitors | HOFFMANN LA ROCHE | 2010-03-24 | — | — | CN | disclosed |
| EP-2089384-A2 | 2-(PIPERIDIN-4-YL)-4-PHENOXY-OR PHENYLAMINO-PYRIMIDINE DERIVATIVES AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | F. Hoffmann-Roche AG (CH) | 2009-08-19 | — | — | EP | disclosed |
| CN-101501002-A | Non-nucleoside reverse transcriptase inhibitors | HOFFMANN LA ROCHE (CH) | 2009-08-05 | — | — | CN | disclosed |
| EP-2057125-A1 | NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | F. Hoffmann-Roche AG (CH) | 2009-05-13 | — | — | EP | disclosed |
| CN-101291905-A | Phenylacetamide NNRT Inhibitors | HOFFMANN LA ROCHE (CH) | 2008-10-22 | — | — | CN | disclosed |
| EP-1940781-A1 | PHENYL-ACETAMIDE NNRT INHIBITORS | F.HOFFMANN-LA ROCHE AG (CH) | 2008-07-09 | — | — | EP | disclosed |
| EP-1940782-A1 | N-PHENYL PHENYLACETAMIDE NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INIHIBITORS | F.HOFFMANN-LA ROCHE AG (CH) | 2008-07-09 | — | — | EP | disclosed |
| EP-1937651-A1 | NNRT INHIBITORS | F.HOFFMANN-LA ROCHE AG (CH) | 2008-07-02 | — | — | EP | disclosed |
| WO-2008071587-A2 | 2-(PIPERIDIN-4-YL)-4-PHENOXY- OR PHENYLAMINO-PYRIMIDINE DERIVATIVES AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2008-06-19 | — | — | WO | disclosed |
| WO-2008019968-A1 | NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2008-02-21 | — | — | WO | disclosed |
| WO-2007045573-A1 | PHENYL-ACETAMIDE NNRT INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2007-04-26 | — | — | WO | disclosed |
| WO-2007045572-A1 | N-PHENYL PHENYLACETAMIDE NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INIHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2007-04-26 | — | — | WO | disclosed |
| WO-2007039463-A1 | NNRT INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2007-04-12 | — | — | WO | disclosed |